References
- Ehsanullah K SB, Page M C., Tildesley G, Wood JK. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: Controllcd trial of ranitidine. BMJ 1988; 297: 1017–21
- Kobinson M G., Griffin J W., Bowers J., et al. Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs. Dig Dis Sci 1989; 34: 424–8
- Oddsson E, Gudjonsson H, Thjodlcifsson B. Protective effect of omeprazole or ranitidine against naproxcn induced damage to the human gastroduodenal mucosa. Scand J Gastroenterol 1990; 25: 25, Suppl. 176
- Agrawal N, Koth S, Graham D Y., et al. Misoprostol compared with sucralfate in the prevention of non-steroidal anti-inflammatory drug-induced gastric ulcer. Ann Intern Med 1991; 115: 195–200
- Graham D Y., Agrawal N M., Roth SH. Prevention of NSAID-induced gastric ulcer with misoprostol: Multicentre, double-blind, placebo-controlled trial. Lancet 1988; 2: 1277–80
- Geis GS. Data on file. G.D. Searle, Skokie, Illinois
- Graham D Y., Stromatt S C., Jaszewski R. Prevention of duodenal ulcer in arthritics who are chronic NSAID users: A multicenter trial of the role of misoprostol. Gastroenterol 1991; 100: A75, Abstract. Data not included in abstract presented at AGA/AASLD, May 1991, New Orleans, LA.
- Raskin J, White R, Jaszewski R. Double-blind comparative study of the efficacy and safety of misoprostol and ranitidine in the prevention of NSAID-induced gastric ulcers and upper GI symptoms: Preliminary findings. Digestion 1991; 49: 50–1, Abstract. Suppl. 1